Renal failure , chronic
Clinical trials for Renal failure , chronic explained in plain language.
Never miss a new study
Get alerted when new Renal failure , chronic trials appear
Sign up with your email to follow new studies for Renal failure , chronic, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can an IV boost beat pills for B12 deficiency in kidney dialysis?
Disease control CompletedThis trial asks whether an intravenous (IV) injection of vitamin B12 works better than oral tablets to correct B12 deficiency in adults on long-term hemodialysis. Participants receive either a weekly IV dose after dialysis or oral tablets three times a day for four weeks. Researc…
Matched conditions: RENAL FAILURE , CHRONIC
Sponsor: Jinnah Hospital • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Exercise and diet may slow early kidney damage
Disease control CompletedThis study looked at whether a 12-week program of exercise, a protein-controlled diet, and education could improve health in people with early-stage kidney disease (stages G1 and G2). Fifteen participants completed the program. Researchers measured changes in cholesterol, muscle …
Matched conditions: RENAL FAILURE , CHRONIC
Sponsor: University of Guadalajara • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Robotic parrot and music soothe dialysis Patients' anxiety and fatigue
Symptom relief CompletedThis study tested whether listening to live music, hearing a ney flute, or interacting with a robotic parrot could help people on dialysis feel less anxious and less tired. 64 adults on regular hemodialysis took part. Researchers measured their anxiety and fatigue levels before, …
Matched conditions: RENAL FAILURE , CHRONIC
Sponsor: Karadeniz Technical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
How does severe kidney disease affect a new Drug's levels?
Knowledge-focused CompletedThis completed Phase 1 study looked at how the drug MK-5684 behaves in the body of men with severe kidney disease or end-stage renal disease compared to healthy men. Twenty-four participants received a single dose, and researchers measured drug levels in the blood over time. The …
Matched conditions: RENAL FAILURE , CHRONIC
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC